A Study to Evaluate the Immunogenicity of Quadrivalent LAIV (MEDI8662) in Adults 18 to 49 Years of Age
Public ClinicalTrials.gov record NCT00952705. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Partially Blind Active Controlled Study to Evaluate the Immunogenicity of MEDI8662 in Adults 18 to 49 Years of Age
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study was to show that quadrivalent live attenuated influenza vaccine (Q/LAIV-BFS; MEDI8662) was at least as immunogenic as two different forms of the commercial vaccine, FluMist, by comparing the strain-specific antibody levels in the blood.
Study identification
- NCT ID
- NCT00952705
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,800 participants
Conditions and interventions
Interventions
- Q/LAIV-BFS (MEDI8662) Biological
- FluMist/B/Yamagata Biological
- FluMist/B/Victoria Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years to 49 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2009 (Type not available)
- Primary completion
- Jan 2010 (Actual)
- Completion
- Mar 2010 (Actual)
- Last update posted
- May 3, 2018
2009 – 2010
United States locations
- U.S. sites
- 18
- U.S. states
- 11
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Coastal Clinical Research, Inc. | Mobile | Alabama | 36608 | — |
| Benchmark Research | Sacramento | California | 95816 | — |
| California Research Foundation | San Diego | California | 92103-6204 | — |
| Benchmark Research | San Francisco | California | 94102 | — |
| Tampa Bay Medical Research, Inc. | Clearwater | Florida | 33761 | — |
| Avail Clinical Research, LLC | DeLand | Florida | 32720 | — |
| Miami Research Associates | Miami | Florida | 33143 | — |
| Clinical Research Atlanta | Stockbridge | Georgia | 30281 | — |
| Johnson County Clin-Trials | Lenexa | Kansas | 66219 | — |
| Vince and Associates Clinical Research | Overland Park | Kansas | 66212 | — |
| Benchmark Research | Metairie | Louisiana | 70006 | — |
| Sundance Clinical Research | St Louis | Missouri | 63141 | — |
| Meridian Clinical Research, LLC | Omaha | Nebraska | 68134 | — |
| Regional Clinical Research | Endwell | New York | 13760 | — |
| Rochester Clinical Research Inc. | Rochester | New York | 14609 | — |
| Palmetto Medical Research | Mt. Pleasant | South Carolina | 29464 | — |
| Benchmark Research Austin | Austin | Texas | 78705 | — |
| Benchmark Research Ft. Worth | Fort Worth | Texas | 76135 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00952705, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 3, 2018 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00952705 live on ClinicalTrials.gov.